BriaCell Therapeutics Corp. (BCT.TO)
5.14
+0.32
(+6.64%)
CAD |
TSX |
Aug 25, 16:00
BriaCell Therapeutics Shareholders Equity (Quarterly) : 32.75M for April 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 32.75M |
| January 31, 2026 | 41.87M |
| October 31, 2025 | 13.98M |
| July 31, 2025 | 24.72M |
| April 30, 2025 | 17.15M |
| January 31, 2025 | 5.218M |
| October 31, 2024 | 5.635M |
| July 31, 2024 | -3.291M |
| April 30, 2024 | -8.195M |
| January 31, 2024 | -10.79M |
| October 31, 2023 | 3.778M |
| July 31, 2023 | -4.972M |
| April 30, 2023 | -7.992M |
| January 31, 2023 | -1.709M |
| October 31, 2022 | 14.10M |
| July 31, 2022 | |
| April 30, 2022 | 58.56M |
| January 31, 2022 | 60.66M |
| October 31, 2021 | 68.66M |
| July 31, 2021 | |
| April 30, 2021 | 16.97M |
| January 31, 2021 | -4.525M |
| October 31, 2020 | -4.489M |
| July 31, 2020 | -4.420M |
| April 30, 2020 | -3.824M |
| Date | Value |
|---|---|
| January 31, 2020 | -2.989M |
| October 31, 2019 | -1.075M |
| July 31, 2019 | -0.8461M |
| April 30, 2019 | 0.8659M |
| January 31, 2019 | -0.7947M |
| October 31, 2018 | 0.4746M |
| July 31, 2018 | 1.231M |
| April 30, 2018 | 3.017M |
| January 31, 2018 | 0.5795M |
| October 31, 2017 | 1.267M |
| July 31, 2017 | 0.9351M |
| April 30, 2017 | 2.152M |
| January 31, 2017 | 1.784M |
| October 31, 2016 | 2.165M |
| July 31, 2016 | 1.028M |
| April 30, 2016 | 1.426M |
| January 31, 2016 | 0.7298M |
| October 31, 2015 | 1.142M |
| July 31, 2015 | 1.508M |
| April 30, 2015 | 1.859M |
| January 31, 2015 | 2.100M |
| October 31, 2014 | 0.6827M |
| July 31, 2014 | 0.8196M |
| April 30, 2014 | 8.855M |
| January 31, 2014 | 9.453M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Kane Biotech, Inc. | -1.418M |
| Quest PharmaTech, Inc. | 26.43M |
| Vaxil Bio Ltd. | 1.194M |
| Waverley Pharma, Inc. | -2.725M |
| Goldcoast Resource Corp. | 0.6796M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 36.85M |
| Total Liabilities (Quarterly) | 4.985M |
| Current Ratio | 7.072 |